Hi Joseph,
Yes with very good news possible for a FDA granting an interim review together with a full reimbursement decision in February all highly likely , SSH is in breakout mode , if we get both that could to a 50% partnership deal for the EU sale rights , I am a believer the fully implantable will be the game changer, as Dr Cowe says disruptive!
the angina and depression market is bigger than class 3/4 , SSH deserves a market cap over $2 billion with all this happening , cheers
- Forums
- ASX - By Stock
- SHC
- Prospects for 2015
Prospects for 2015, page-2
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)